Patents Assigned to Cormend Technologies, LLC
-
Patent number: 9931375Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.Type: GrantFiled: May 27, 2016Date of Patent: April 3, 2018Assignee: CORMEND TECHNOLOGIES, LLCInventors: William P. Santamore, Jeanne M. Lesniak
-
Publication number: 20160279200Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.Type: ApplicationFiled: May 27, 2016Publication date: September 29, 2016Applicant: Cormend Technologies, LLCInventors: William P. SANTAMORE, Jeanne M. LESNIAK
-
Publication number: 20160235820Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying at least one target region of the myocardium of the heart to be treated; and injecting a keratin-based material that travels to at least one target region to at least one of stiffen, restrain, or constrain the myocardial tissue of the target region. The material applied results in a physical modification of the mechanical properties, including stiffness, of the infarct tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.Type: ApplicationFiled: February 17, 2016Publication date: August 18, 2016Applicant: Cormend Technologies, LLCInventor: John C. ANDRES
-
Patent number: 9381157Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.Type: GrantFiled: December 4, 2014Date of Patent: July 5, 2016Assignee: CORMEND TECHNOLOGIES, LLCInventors: William P. Santamore, Jeanne M. Lesniak
-
Patent number: 8936027Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.Type: GrantFiled: May 26, 2011Date of Patent: January 20, 2015Assignee: Cormend Technologies, LLCInventors: William P. Santamore, Jeanne M. Lesniak
-
Patent number: 8452419Abstract: Medical devices and therapeutic methods for use in the field of cardiology, cardiac rhythm management and interventional cardiology, and more specifically to catheter-based systems for implantation of pacing leads and electrodes, or intramural myocardial reinforcement devices, within the myocardial wall of the heart, such as the ventricles, to provide improved cardiac function.Type: GrantFiled: July 12, 2010Date of Patent: May 28, 2013Assignee: Cormend Technologies, LLCInventors: William P. Santamore, Jeanne M. Lesniak
-
Publication number: 20120109044Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.Type: ApplicationFiled: May 26, 2011Publication date: May 3, 2012Applicant: CORMEND TECHNOLOGIES, LLCInventors: William P. Santamore, Jeanne M. Lesniak
-
Patent number: 7988727Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.Type: GrantFiled: October 4, 2004Date of Patent: August 2, 2011Assignee: Cormend Technologies, LLCInventors: William P. Santamore, Jeanne M. Lesniak